Found 5 matching trials
A Multiple Dose Study of BAY1834845 in Healthy Male Subjects and in Patients With Psoriasis PHASE1 To assess safety and tolerability of multiple oral doses of BAY1834845 in h...
Show More Location
Charité Research Organisation GmbH
Learn More & Join Trial
A Trial to Learn How BAY1834845 and BAY1830839 Affect Inflammation When Taken by Mouth Twice a Day for 7 Days in a Row in Healthy Male Participants PHASE1 The immune system helps protect the body from diseases. But, sometimes the ...
Show More Location
Center for Human Drug Research
Learn More & Join Trial
A Study to Learn How Well the Study Treatment Zabedosertib (BAY1834845) Works and How Safe it is Compared to Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis PHASE2 Researchers are looking for a better way to treat atopic dermatitis (AD), a...
Show More Location
NorthShore University HealthSystem | Skokie Hospital - Dermatology Department
Learn More & Join Trial
First in Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and to Explore Pharmacodynamics of BAY1834845 PHASE1 This study is a first in human study that will investigate the safety, tole...
Show More Location
CRS Clinical Research Services Berlin GmbH
Learn More & Join Trial
Food Effect, Oral & Intravenous Pharmacokinetics and Absolute Bioavailability of BAY1834845 Including Drug-drug Interaction With Methotrexate PHASE1 This study is planned to explore the effect of food on the oral pharmacokin...
Show More Location
PRAHealthSciences
Learn More & Join Trial